Pfizer And University College London Announce Collaboration To Advance Development Of Stem Cell-Base
|
25 April 2009 |
Pfizer and Medicines for Malaria Venture Advancing International Research Efforts
|
23 April 2009 |
The First Pharmaceutical Company for Protection of Human Rights in Clinical Research
|
07 April 2009 |
Pfizer Development Pipeline Shows Advances In High-Priority Disease Areas
|
03 April 2009 |
Significantly More Patients With Cardiovascular Disease Quit Smoking Using Chantix/Champix®
|
01 April 2009 |
U.S. Patent & Trademark Office Grants Reissue Patent Relating to Lipitor
|
18 March 2009 |
Pfizer Expands Portfolio of Generic Medicines in the U.S. and Europe
|
03 March 2009 |
Pfizer Discontinues Development of Two Phase 3 Compounds
|
25 February 2009 |
Pfizer to Disclose Payments to US Physicians, Healthcare Professionals and Clinical Investigators
|
10 February 2009 |
Pfizer and The Pfizer Foundation Recognize "World Cancer Day"
|
09 February 2009 |
Lipitor Significantly Reduced hsCRP Levels in Patients with Stable Coronary Artery Disease
|
03 February 2009 |
Pfizer Discontinues Global Phase III Trial of Axitinib
|
31 January 2009 |
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
|
26 January 2009 |
Pfizer Receives FDA Complete Response Letter for Lasofoxifene
|
17 January 2009 |
U.S. Patent and Trademark Office Accepts Pfizer's Reissue Application on Lipitor
|
06 January 2009 |
Pfizer and Sigma-Tau Announce an Agreement to Market a Potential New Treatment for Malaria
|
10 December 2008 |
Pfizer's Novel HIV/AIDS Treatment SELZENTRY™
|
27 November 2008 |
Pfizer withdraws its application to change the marketing authorisation for Viagra
|
20 November 2008 |
Pfizer Launches Global Regenerative Medicine Research Unit
|
14 November 2008 |
Pfizer and UCB Announce Formation of New Company Cyclofluidic to Accelerate Drug Discovery Process
|
21 October 2008 |